OncoCyte (STU:7OC0) Other Stockholders Equity : €-0.00 Mil (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is OncoCyte Other Stockholders Equity?

OncoCyte's Other Stockholders Equity for the quarter that ended in Dec. 2023 was €-0.00 Mil.

OncoCyte's quarterly Other Stockholders Equity increased from Jun. 2023 (€-0.00 Mil) to Sep. 2023 (€0.00 Mil) but then declined from Sep. 2023 (€0.00 Mil) to Dec. 2023 (€-0.00 Mil).

OncoCyte's annual Other Stockholders Equity declined from Dec. 2021 (€0.00 Mil) to Dec. 2022 (€-0.00 Mil) and declined from Dec. 2022 (€-0.00 Mil) to Dec. 2023 (€-0.00 Mil).

OncoCyte Other Stockholders Equity Historical Data

The historical data trend for OncoCyte's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OncoCyte Other Stockholders Equity Chart

OncoCyte Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Stockholders Equity

Get a 7-Day Free Trial

OncoCyte Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Stockholders Equity	Get a 7-Day Free Trial															-	-	-	-	-

OncoCyte Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

OncoCyte Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of OncoCyte's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

OncoCyte (STU:7OC0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » OncoCyte Corp (STU:7OC0) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

OCX:USA

Address

15 Cushing, Irvine, CA, USA, 92618

Website

https://www.oncocyte.com

OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, it also develops screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers. Geographically operation of the group is carried through the United States.

OncoCyte (STU:7OC0) Headlines

No Headlines